GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Optipharm Co Ltd (XKRX:153710) » Definitions » Short Percentage of Float

Optipharm Co (XKRX:153710) Short Percentage of Float


View and export this data going back to 2018. Start your Free Trial

What is Optipharm Co Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Optipharm Co's Short Percentage of Float

For the Diagnostics & Research subindustry, Optipharm Co's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Optipharm Co's Short Percentage of Float Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Optipharm Co's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Optipharm Co's Short Percentage of Float falls into.


;
;

Optipharm Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Optipharm Co Ltd (XKRX:153710) » Definitions » Short Percentage of Float
Comparable Companies
XKRX:347740 XKRX:122310 XKRX:950200 XKRX:376930 XKRX:363250 XKRX:109820 XKRX:217330 XKRX:384470 XKRX:180400 XKRX:086040 TMO DHR XSWX:LONN IDXX A SHSE:603259 IQV MTD NTRA WAT
Traded in Other Exchanges
N/A
Address
6, 63 Osong, Hwaseong-eup, Heungduk-gu, Chungcheongbuk-do, Cheongju, KOR
Website
http://www.optipharm.co.kr
Optipharm Co Ltd is engaged in developing cell therapy products through animal stem cells, developing high value-added protein drugs using bio-reactors, selecting antibiotic/antiviral components and developing products. Its diagnosis division includes human diagnosis and animal diagnosis that focuses on the development of molecular diagnostics for a variety of diseases.

Optipharm Co Headlines

No Headlines